Search

Displaying results 7021 - 7030 of 10000 in total
  1. Drug

    Fipamezole

    go.drugbank.com/drugs/DB06585
    Investigational

  2. Drug

    TRU-015

    go.drugbank.com/drugs/DB05580
    Investigational

  3. Drug

    CRD5

    go.drugbank.com/drugs/DB05587
    Experimental

  4. Drug

    Freselestat

    go.drugbank.com/drugs/DB03925
    Experimental

  5. Drug

    Emfilermin

    go.drugbank.com/drugs/DB06562
    Investigational

  6. Drug

    Fibroblast growth factor-1

    go.drugbank.com/drugs/DB05599
    Investigational

  7. Drug

    CTCE-9908

    go.drugbank.com/drugs/DB05625
    Investigational

    Synonyms: L-Lysinamide,N2,N6-bis(L-lysylglycyl-L-valyl-L-seryl-L-leucyl-L-seryl-L-tyrosyl-L-arginyl)-
  8. Drug

    Pemoline

    go.drugbank.com/drugs/DB01230
    ApprovedIllicitWithdrawn

    In 2005, the Food and Drug Administration (FDA) withdrew approval for pemoline. In March 2005, Abbott Laboratories (Cylert marketer) had discontinued the production of Cylert arguing economic reasons.

  9. Drug

    Methapyrilene

    go.drugbank.com/drugs/DB04819
    ApprovedWithdrawn

    Methapyrilene, formerly marketed in many drug products, was shown to be a potent carcinogen. Manufacturers voluntarily withdrew methapyriline drug products from the market in May and June 1979.

    Synonyms: N,N-dimethyl-N'-pyrid-2-yl-N'-2-thenylethylenediamine, N,N-dimethyl-N'-pyridin-2-yl-N'-(2-thienylmethyl)ethane-1,2-diamine
  10. Drug

    Nesvategrast

    go.drugbank.com/drugs/DB19337
    Investigational

    Nesvategrast is under investigation in clinical trial NCT05409235 (Nesvategrast (OTT166) in Diabetic Retinopathy (DR)).

    Synonyms: (s)-3-(6-(difluoromethoxy)pyridin-3-yl)-3-(oxo-2-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)imidazolidin-1-yl)propanoate, βS)-6-(Difluoromethoxy)-β-[2-oxo-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]-1-imidazolidinyl]-3-pyridinepropanoic acid